BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20031628)

  • 61. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
    Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?
    Angiolillo DJ; Fernández-Ortiz A; Bernardo E; Barrera Ramírez C; Sabaté M; Fernandez C; Hernández-Antolín R; Escaned J; Alfonso F; Macaya C
    J Invasive Cardiol; 2004 Apr; 16(4):169-74. PubMed ID: 15152138
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.
    Lev EI; Arikan ME; Vaduganathan M; Alviar CL; Tellez A; Mathuria N; Builes A; Granada JF; del Conde I; Kleiman NS
    Am Heart J; 2007 Oct; 154(4):694.e1-7. PubMed ID: 17892993
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.
    Gurbel PA; Bliden KP; Hiatt BL; O'Connor CM
    Circulation; 2003 Jun; 107(23):2908-13. PubMed ID: 12796140
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
    Gurbel PA; Cummings CC; Bell CR; Alford AB; Meister AF; Serebruany VL;
    Am Heart J; 2003 Feb; 145(2):239-47. PubMed ID: 12595840
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
    Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
    Antonino MJ; Mahla E; Bliden KP; Tantry US; Gurbel PA
    Am J Cardiol; 2009 Jun; 103(11):1546-50. PubMed ID: 19463513
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention.
    Kassimis G; Davlouros P; Xanthopoulou I; Stavrou EF; Athanassiadou A; Alexopoulos D
    Thromb Res; 2012 Apr; 129(4):441-6. PubMed ID: 21831410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
    Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers.
    Price MJ; Teirstein PS
    Am J Cardiol; 2008 Sep; 102(6):790-5. PubMed ID: 18774008
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of C3435T multidrug resistance gene-1 (MDR-1) polymorphism on platelet reactivity and prognosis in patients with acute coronary syndromes.
    Spiewak M; Małek ŁA; Kostrzewa G; Kisiel B; Serafin A; Filipiak KJ; Płoski R; Opolski G
    Kardiol Pol; 2009 Aug; 67(8):827-34. PubMed ID: 19784880
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients.
    Harmsze AM; Van Werkum JW; Moral F; Ten Berg JN; Hackeng CM; Klungel OH; De Boer A; Deneer VH
    Platelets; 2011; 22(2):98-102. PubMed ID: 21142408
    [TBL] [Abstract][Full Text] [Related]  

  • 75. P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting.
    Zoheir N; Abd Elhamid S; Abulata N; El Sobky M; Khafagy D; Mostafa A
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):525-31. PubMed ID: 23751603
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy].
    Muslimova EF; Afanasiev SA; Rebrova TY; Sergienko TN; Repin AN
    Ter Arkh; 2017; 89(5):74-78. PubMed ID: 28631703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
    Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
    Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelet function after cessation of chronic clopidogrel therapy.
    Perakis PG; Yunus T; Long G; Cheema ZF; Hammond R; Shanley CJ
    Am Surg; 2012 Jan; 78(1):51-6. PubMed ID: 22273313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic kidney disease--is it a true risk factor of reduced clopidogrel efficacy in elderly patients with stable coronary artery disease?
    Leng WX; Ren JW; Cao J; Cong YL; Cui H; Hu GL; Hu QQ; Niu H; Fan L
    Thromb Res; 2013 Mar; 131(3):218-24. PubMed ID: 23340097
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel.
    Yang HH; Chen Y; Gao CY
    Cardiovasc Ther; 2016 Dec; 34(6):460-467. PubMed ID: 27566695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.